Oliver Hopkinson

BioEclipse Therapeutics™ is a clinical-stage oncology company developing a new generation of precise, targeted, immunotherapies that bring hope to patients with advanced cancer who have few treatment options due to the challenges of resistant and recurrent cancers. Solid tumors have been a challenging obstacle for all cancer therapies, including immunotherapies, reporting high failuure rates. For six decades researchers have taken steps towards a cure, with remarkable progress in liquid tumors, but few inroads into solid tumors representing 90% of all cancers. Our technology represents a transformative approach that captures the true power of both innate and adaptive immunity to effectively treat even refractory solid tumors.

TAP Network leverages blockchain technology and powers white-labeled rewards for some of the biggest programs in the world, including Warner Music Group, Uber, Brave and more. Millions of users can redeem points, miles, crypto, fiat currency and more seamlessly with TAPs network of 250,000 top brands and real-world merchant partners everyday.

BioEclipse Therapeutics™ is a clinical-stage oncology company developing a new generation of precise, targeted, immunotherapies that bring hope to patients with advanced cancer who have few treatment options due to the challenges of resistant and recurrent cancers. Solid tumors have been a challenging obstacle for all cancer therapies, including immunotherapies, reporting high failuure rates. For six decades researchers have taken steps towards a cure, with remarkable progress in liquid tumors, but few inroads into solid tumors representing 90% of all cancers. Our technology represents a transformative approach that captures the true power of both innate and adaptive immunity to effectively treat even refractory solid tumors.

TAP Network leverages blockchain technology and powers white-labeled rewards for some of the biggest programs in the world, including Warner Music Group, Uber, Brave and more. Millions of users can redeem points, miles, crypto, fiat currency and more seamlessly with TAPs network of 250,000 top brands and real-world merchant partners everyday.

Revelis Capital Group, LLC ("Revelis"​) is a family office-backed private investment firm with offices in Denver and Aspen, Colorado, focused on providing high net worth individuals and family offices with access to elite early stage direct venture investments. Through our internal network, we have preferred access to some of the most compelling early stage venture deals on the market. We have found that many high net worth individuals and families have an appetite for these high-upside opportunities, but rarely have the resources and exposure necessary to access the very best. Revelis was founded to fill this gap in the marketplace--to identify the most promising deals available and provide direct investment opportunities to investors in demand of quality deal flow. Overview: -Flexible direct investment model -$1m-$5m Series A investments spanning wide range of sectors -Proprietary deal flow with extraordinary upside potential at attractive valuations -Investments vetted and validated by an experienced team of advisors with relevant expertise -Members get direct access to internal diligence process and receive detailed diligence report prepared by Revelis -Active investment approach designed to deliver maximum value to portfolio companies -Heavy focus on risk mitigation and strategic alignment -High-caliber investor base comprised of sophisticated family offices and individual investors Visit our website (https://www.reveliscapitalgroup.com/) for more information, to subscribe to our mailing list, and to access our investor portal.